BBJS Financial Advisors’s Organon & Co OGN Stock Holding History

BBJS Financial Advisors’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-13	Closed	-$363	–	137
2022 Q4	$363	Buy	+13	New	+$332	﹤0.01%	131

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BBJS Financial Advisors's OGN Position: Q1 2023 in Review

BBJS Financial Advisors sold out of Organon & Co (OGN) in Q1 2023, closing a stake of 13 shares — an estimated $363 sold.

BBJS Financial Advisors first reported a position in OGN in Q4 2022 and held it in 1 quarter. The position peaked at $363 in Q4 2022. 767 funds tracked by Wall St. Rank hold OGN as of Q1 2023.

BBJS Financial Advisors reported no remaining Organon & Co position as of Q1 2023 after selling out during the quarter.
BBJS Financial Advisors sold 13 Organon & Co shares in Q1 2023, an estimated $363.
BBJS Financial Advisors first reported a position in Organon & Co in Q4 2022 and held it in 1 quarter.
BBJS Financial Advisors's Organon & Co position peaked at $363 in Q4 2022.
767 funds tracked by Wall St. Rank held Organon & Co as of Q1 2023.

Based on BBJS Financial Advisors's 13F filing for Q1 2023, filed 16 May 2023.